AMPH
Price
$20.95
Change
-$0.72 (-3.32%)
Updated
Jul 31 closing price
Capitalization
2.11B
6 days until earnings call
BHC
Price
$5.89
Change
-$0.50 (-7.82%)
Updated
Jul 31 closing price
Capitalization
3.86B
90 days until earnings call
Interact to see
Advertisement

AMPH vs BHC

Header iconAMPH vs BHC Comparison
Open Charts AMPH vs BHCBanner chart's image
Amphastar Pharmaceuticals
Price$20.95
Change-$0.72 (-3.32%)
Volume$545K
Capitalization2.11B
Bausch Health Companies
Price$5.89
Change-$0.50 (-7.82%)
Volume$4.96M
Capitalization3.86B
AMPH vs BHC Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. BHC commentary
Aug 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Hold and BHC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 01, 2025
Stock price -- (AMPH: $20.96 vs. BHC: $5.89)
Brand notoriety: AMPH: Not notable vs. BHC: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 117% vs. BHC: 257%
Market capitalization -- AMPH: $2.11B vs. BHC: $3.86B
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. BHC’s [@Pharmaceuticals: Other] market capitalization is $3.86B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileBHC’s FA Score has 0 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • BHC’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMPH and BHC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 4 TA indicator(s) are bullish while BHC’s TA Score has 3 bullish TA indicator(s).

  • AMPH’s TA Score: 4 bullish, 4 bearish.
  • BHC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than BHC.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а -6.89% price change this week, while BHC (@Pharmaceuticals: Other) price change was -13.13% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.52%. For the same industry, the average monthly price growth was +6.04%, and the average quarterly price growth was +81.88%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 10, 2025.

BHC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.52% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($3.86B) has a higher market cap than AMPH($2.11B). AMPH has higher P/E ratio than BHC: AMPH (16.69) vs BHC (13.39). BHC YTD gains are higher at: -26.923 vs. AMPH (-43.550). BHC has higher annual earnings (EBITDA): 2.2B vs. AMPH (240M). BHC has more cash in the bank: 947M vs. AMPH (257M). AMPH has less debt than BHC: AMPH (624M) vs BHC (22.4B). BHC has higher revenues than AMPH: BHC (8.76B) vs AMPH (644M).
AMPHBHCAMPH / BHC
Capitalization2.11B3.86B55%
EBITDA240M2.2B11%
Gain YTD-43.550-26.923162%
P/E Ratio16.6913.39125%
Revenue644M8.76B7%
Total Cash257M947M27%
Total Debt624M22.4B3%
FUNDAMENTALS RATINGS
AMPH vs BHC: Fundamental Ratings
AMPH
BHC
OUTLOOK RATING
1..100
6171
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
45100
PRICE GROWTH RATING
1..100
8855
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
n/a49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (35) in the Pharmaceuticals Other industry is in the same range as AMPH (63). This means that BHC’s stock grew similarly to AMPH’s over the last 12 months.

BHC's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as AMPH (100). This means that BHC’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's SMR Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for BHC (100). This means that AMPH’s stock grew somewhat faster than BHC’s over the last 12 months.

BHC's Price Growth Rating (55) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMPH (88). This means that BHC’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's P/E Growth Rating (93) in the Pharmaceuticals Other industry is in the same range as BHC (100). This means that AMPH’s stock grew similarly to BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHBHC
RSI
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
72%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 1 day ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
72%
Aroon
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMCX21.71N/A
N/A
Goldman Sachs Emerging Markets Eq C
NBHIX14.72N/A
N/A
Neuberger Berman Equity Income I
JABCX48.65N/A
N/A
Janus Henderson Balanced C
VCESX16.40N/A
N/A
Virtus KAR Emerging Markets Small-Cap C
IAFMX19.82N/A
N/A
F/m Investments Large Cap Focused Inv

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-3.28%
AMRX - AMPH
40%
Loosely correlated
-3.10%
COLL - AMPH
39%
Loosely correlated
-2.80%
VTRS - AMPH
31%
Poorly correlated
-2.94%
HROW - AMPH
31%
Poorly correlated
-2.81%
PAHC - AMPH
31%
Poorly correlated
-5.09%
More

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and ELAN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
-7.82%
ELAN - BHC
27%
Poorly correlated
-3.12%
ZTS - BHC
27%
Poorly correlated
-2.03%
AMPH - BHC
26%
Poorly correlated
-3.28%
TEVA - BHC
25%
Poorly correlated
-8.20%
ESPR - BHC
25%
Poorly correlated
+1.06%
More